Alan Anderson
- Pharmacology top 0.5%
- Molecular Biology
- Oncology top 10%
- Genetics top 10%
- Cancer Research
- Co-authors
- Eric TrottierYvon TrottierMarkus AffolterChantal CourtemancheMichel GuertinLuc BélangerStéphane DuboisDiane Labbé
- Topics
- Pharmacogenetics and Drug Metabolism (21 papers)Drug Transport and Resistance Mechanisms (15 papers)Carcinogens and Genotoxicity Assessment (8 papers)
In The Last Decade
Alan Anderson
36 papers receiving 818 citations
Peers
Comparison fields: 5 of 72
- Pharmacology 444
- Molecular Biology 360
- Oncology 254
- Genetics 194
- Cancer Research 153
Countries citing papers authored by Alan Anderson
This map shows the geographic impact of Alan Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Anderson more than expected).
Fields of papers citing papers by Alan Anderson
This network shows the impact of papers produced by Alan Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Anderson. The network helps show where Alan Anderson may publish in the future.
Co-authorship network of co-authors of Alan Anderson
This figure shows the co-authorship network connecting the top 25 collaborators of Alan Anderson. A scholar is included among the top collaborators of Alan Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Anderson. Alan Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 16 | |
| 3 | 17 | |
| 4 | 23 | |
| 5 | 7 | |
| 6 | 30 | |
| 7 | 15 | |
| 8 | 84 | |
| 9 | 20 | |
| 10 | 7 | |
| 11 | 16 | |
| 12 | 6 | |
| 13 | 37 | |
| 14 | 9 | |
| 15 | 36 | |
| 16 | 30 | |
| 17 | 10 | |
| 18 | 12 | |
| 19 | 45 | |
| 20 | 17 |
About Alan Anderson
Alan Anderson is a scholar working on Pharmacology, Oncology and Cancer Research, having authored 36 papers that have together received 838 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (21 papers), Drug Transport and Resistance Mechanisms (15 papers) and Carcinogens and Genotoxicity Assessment (8 papers). The work is most often cited by research in Pharmacology (444 citations), Biochemistry (76 citations) and Cancer Research (153 citations). Alan Anderson has collaborated with scholars based in Canada, France and Australia. Frequent co-authors include Eric Trottier, Yvon Trottier, Markus Affolter, Chantal Courtemanche, Michel Guertin, Luc Bélanger, Stéphane Dubois, Diane Labbé, Jacek Bartkowiak and Étienne Audet‐Walsh. Their work appears in journals such as Journal of Biological Chemistry, Biochemistry and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.